TSHR and geroderma osteodysplastica: The plasma PCSK9 level was elevated in GO patients and positively correlated with clinical inflammation and thyrotropin receptor antibody titer, indicating that PCSK9 is a potential biomarker for diagnosis and prognosis of GO.